You searched for "diagnostic"
My Top Five: Promising gene therapies for ocular conditions
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...My Top Five: Promising gene therapies for ocular conditions
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...Understanding vasoproliferative retinal tumours
Syed Irtiza Ali Shah explores this rare and unusual condition through a fascinating case presentation. Vasoproliferative tumours of the retina (VPTR) are a vascular mass with an associated exudative retinopathy alongside the presence of minimally dilated feeder vessels. This is...New study maps priorities for UK eyecare research
Glaucoma, age-related macular degeneration, childhood vision loss, and short-sightedness are highlighted as target study areas.Standby for standards: Ophthalmic imaging
The Ophthalmic Imaging Associating (OIA) will propose and publish a volume of refined standards for Ophthalmic and Vision Science. These will be reviewed by the OIA membership at its annual conference in November 2025 and released thereafter. The OIA is...Newmedica welcomes GIRFT glaucoma guidance but calls for equitable commissioning to protect patient access
Newmedica has welcomed the publication of NHS England’s Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services, recognising it as an important step toward improving consistency and outcomes for patients across England. The guidance’s emphasis on patient...
Neurofibromatosis type 1 features
The aim in this study was to identify the incidence and de nova mutation rate of Neurofibramatosis type 1 (NF1) and describe the ocular and non-ocular findings in a population-based cohort of patients diagnosed over a 30-year period. The study...World leaders in eyecare mark Centre for Sight’s 30 years of vision care
East Grinstead became the UK hotspot for groundbreaking vision care as some of the biggest names in global ophthalmology gathered to mark the 30th anniversary of Centre for Sight. The internationally recognised eye hospital, founded in 1996 by consultant ophthalmic...
Pseudostrabismus leading to strabismus
The authors aimed to evaluate the incidence of strabismus in children initially diagnosed with pseudostrabismus and identify risk factors for development of strabismus. This was a retrospective review of 65 patients with a diagnosis of pseudostrabismus; two exo and 63...
